Cargando…

Use of subcutaneous immunoglobulin in inflammatory myositis

Detalles Bibliográficos
Autores principales:	Zhou, Alan L, Maltez, Nancy, Ivory, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letter to the Editor (Other)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528003/ https://www.ncbi.nlm.nih.gov/pubmed/34676354 http://dx.doi.org/10.1093/rap/rkab070

Ejemplares similares

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases
por: Cherin, Patrick, et al.
Publicado: (2015)

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
por: Ballow, Mark, et al.
Publicado: (2017)

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)

COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?
por: Movahedi, Nasim, et al.
Publicado: (2021)

Myositis Ossificans of the Masseter Muscle
por: Kayal, L., et al.
Publicado: (2018)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

Orbital myositis in systemic lupus erythematosus
por: Hernandez Fustes, Otto J.
Publicado: (2021)

A Case of Nivolumab-Induced Myositis
por: Fox, Eric, et al.
Publicado: (2016)

Response to the Letter to the Editor Regarding “Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials”
por: Suez, Daniel, et al.
Publicado: (2017)

Myelitis with Myositis - An Unusual Neurological Complication of COVID-19
por: Pereira, Amanda L., et al.
Publicado: (2022)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Near-Fatal Statin-Associated Autoimmune Myositis
por: Vithayathil, Mathew, et al.
Publicado: (2018)

Rimmed Vacuoles in Myositis Associated with Antimitochondrial Antibody
por: Shimazaki, Rui, et al.
Publicado: (2020)

Perioperative management of immune-mediated necrotizing myositis
por: Montané-Muntané, Mar, et al.
Publicado: (2022)

Acute orbital myositis before Herpes zoster ophthalmicus
por: Kim, Hyung Tae, et al.
Publicado: (2012)

Levator palpebrae superioris myositis: An uncommon cause of ptosis
por: Lai, Karen Hei-tung, et al.
Publicado: (2020)

12. When is inflammatory myositis not inflammatory myositis?
por: McShane, Annmarie, et al.
Publicado: (2019)

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm
por: Haddox, C. L., et al.
Publicado: (2017)

Features of diaphragmatic myositis in a case of sudden infant death
por: Eisenhut, Michael
Publicado: (2011)

Meningoencephalitis, myositis, and rash-neurological presentation of Indian tick typhus
por: Nigam, Gaurav, et al.
Publicado: (2016)

Anti-mitochondrial antibody-associated myositis with eosinophilia and dropped head
por: Shimizu, Hayato, et al.
Publicado: (2018)

Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis
por: Chun, June Young, et al.
Publicado: (2017)

A Case of Myositis Preceding Neuropathy in Eosinophilic Granulomatosis with Polyangiitis
por: Woo, Kyoungnam, et al.
Publicado: (2020)

Thymoma-Associated Paraneoplastic Myositis, Presenting with Rapidly Progressive Muscle Contractures
por: Kim, Jin Hee, et al.
Publicado: (2021)

Inclusion body myositis and Sjögren’s syndrome: the association works both ways
por: Giannini, Margherita, et al.
Publicado: (2022)

Immunoglobulins as steroid sparing agents in chronic relapsing inflammatory optic neuropathy
por: Gonzalez-Granado, Luis I.
Publicado: (2010)

Solitary immunoglobulin G4-related inflammatory pseudotumor in the abdomen wall
por: Kim, Yunsuek, et al.
Publicado: (2017)

Subcutaneous Hematoma following Subcutaneous Emphysema: An Occult Association
por: Khandelwal, Ankur, et al.
Publicado: (2017)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

The Value of Intravenous Immunoglobulin Therapy in Idiopathic Inflammatory Myositis in the Current Transformed Era of Biologics
por: Patwardhan, Anjali
Publicado: (2020)

Is serum cholinesterase level a predictor of the extent of organ involvement in immunoglobulin G4-related disease?
por: Hamada-Ode, Kazu, et al.
Publicado: (2020)

Exercise in Myositis
por: Alexanderson, Helene
Publicado: (2018)

Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients
por: Danieli, Maria Giovanna, et al.
Publicado: (2022)

Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy
por: Goyal, Namita A., et al.
Publicado: (2021)

Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2021)

Spinal Cord and Motor Neuron TDP-43 Pathology in a Sporadic Inclusion Body Myositis Patient
por: Cathcart, Sahara J, et al.
Publicado: (2020)

Subcutaneous sarcoidosis on the digits
por: Norikawa, Natsumi, et al.
Publicado: (2020)

A Case of Focal Eosinophilic Myositis Associated with Hypereosinophilic Syndrome: A Rare Case Report
por: Jung, Joon Min, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i2q05kb96ck3n7jjcb6t1po9se